| Page 1282 | Kisaco Research
 

David Vereide

iPSC Lead
Umoja Biopharma

David Vereide

iPSC Lead
Umoja Biopharma

David Vereide

iPSC Lead
Umoja Biopharma

ESG Testimonial 2

I was sent to this event to learn how our organization can begin the journey that is ESG. Without knowing what to expect, I came away with a wide array of knowledge, best practices, and practical applications that will help my organization achieve ESG goals. Every delegate, speaker, and panelist I met were well informed and shared their knowledge and experience with me. And I met some colleagues that I can count on to share ESG information and best practices for the future. We are all in this together and that was a central theme of this program.

 

Teisha Rowland

iPSC Lead
Umoja Biopharma

Teisha Rowland

iPSC Lead
Umoja Biopharma

Teisha Rowland

iPSC Lead
Umoja Biopharma
 

Lan Cao

VP, Head of Cell Therapy Innovation Group
Takeda

Lan Cao

VP, Head of Cell Therapy Innovation Group
Takeda

Lan Cao

VP, Head of Cell Therapy Innovation Group
Takeda
 

Mark Plavsic

Chief Technical Officer
Fate Therapeutics

Mark Plavsic

Chief Technical Officer
Fate Therapeutics

Mark Plavsic

Chief Technical Officer
Fate Therapeutics
 

Allison Hubel

Director
Technological Leadership Institute, University of Minnesota

Allison Hubel

Director
Technological Leadership Institute, University of Minnesota

Allison Hubel

Director
Technological Leadership Institute, University of Minnesota

ESG Testimonial 1

The summit was fantastic! The speakers were well selected, and the presentations were helpful especially as I begin viewing our business through the ESG lens.

 

Stefan Frank

Associate Director iPSC Platform Strategy
Bayer

Stefan Frank

Associate Director iPSC Platform Strategy
Bayer

Stefan Frank

Associate Director iPSC Platform Strategy
Bayer
 

Gregory Fiore

CEO
Exacis Biosciences

Gregory Fiore

CEO
Exacis Biosciences

Gregory Fiore

CEO
Exacis Biosciences
 

Jay Mills

Director of Process Development
Century Therapeutics

Jay Mills

Director of Process Development
Century Therapeutics

Jay Mills

Director of Process Development
Century Therapeutics